Background: Genetic polymorphisms of Toll-like receptors (TLR) may influence the outcome of Helicobacter pylori infection and play important roles in gastric carcinogenesis. To screen the genetic variants of TLR2 and TLR5, and evaluate their associations with gastric cancer (GC) and its precursors, a population-based study was conducted in Linqu County, Shandong Province, China.
Introduction
Helicobacter pylori is a microaerophilic gram negative bacterium which colonizes the human stomach and establishes long-term infection in the gastric mucosa (1) . It is believed that persistent H. pylori infection induces chronic inflammation, which could result in a transition from normal mucosa to chronic atrophic gastritis (CAG) and increase the risk of gastric cancer (GC; refs. 2, 3). About 50% of the world's population is infected with H. pylori, and the prevalence of H. pylori infection is very high (>70%) in Linqu County, Shandong Province, China (4); however, only a small proportion of infected subjects eventually develop GC, suggesting that genetic variation may influence gastric carcinogenesis (5) . In recent years, we and others have reported that genetic polymorphisms in inflammatory response-related genes such as interleukin (IL)-8 and IL-10 contribute to susceptibility of GC and its precursors (6) (7) (8) . Toll-like receptors (TLR), which are thought to play a critical role in H. pylori induced chronic inflammation, may also be implicated in GC susceptibility.
TLRs, the pattern recognition receptors, recognize pathogen-associated molecular patterns and endogenous ligands. Stimulation of the TLR pathway induces NF-kB activation and transcription of immune response genes such as cytokines and chemokines, leading to the activation of innate immunity and regulation of acquired immunity (9) . To date, 10 members of the TLR family have been identified in humans (10) , in which TLR2, 4, 5, and 9 are reported to be involved in H. pylori recognition (11) (12) (13) (14) (15) (16) (17) (18) . TLR2 was shown to recognize H. pylori lipopolysaccharide (LPS) (11) . Moreover, TLR2 binds to H. pylori neutrophil-activating protein, triggering a Th1 immune response (12) . The role of TLR4 in recognizing H. pylori LPS has been reported controversially (11, 13) . TLR5 is expressed in gastric mucosa (14, 15) . H. pylori flagellin is a TLR5 agonist in vitro (11, 16) , whereas some conflicting reports show that H. pylori flagellin evades TLR5 recognition, which may contribute to its long-term persistence in hosts (19, 20) . TLR9 could recognize H. pylori CpG DNA, leading to the induction of cytokine secretion (17, 18) .
Recently, genetic variants of TLR2 were found to be associated with susceptibility of colorectal cancer, cervical cancer, gallbladder cancer, and GC (21) (22) (23) (24) (25) ; however, no study on TLR2 polymorphisms and risk of GC and its precursors in a Chinese population has yet been reported. A previous study has suggested that TLR4 Asp299Gly was associated with GC in Caucasians (26) ; but this polymorphism was not detected in Chinese patients (27) (28) (29) . Moreover, although genetic polymorphisms of TLR5 have been characterized in the Caucasian population, no study was reported on its relationship with cancer susceptibility. A functional polymorphism TLR9-1237T>C was associated with H. pylori-induced premalignant gastric disease (30) , but this polymorphism was rare in the Chinese population (31) .
In our current study, we were particularly interested to characterize the profile of TLR2 and TLR5 polymorphisms and investigated their roles in the H. pylori-associated gastric carcinogenesis. We screened the promoter region and the entire coding region of TLR2 and TLR5, and investigated the potentially functional polymorphisms and risk of GC. We also evaluated the associations between these polymorphisms and risk of advanced gastric lesions including intestinal metaplasia (IM) and dysplasia (DYS), and possible interactions between functional polymorphisms and H. pylori infection.
Materials and Methods
In 1994 and 2002, we launched 2 independent intervention trials of GC in Linqu County. These trials were aimed to test the effects of H. pylori treatment, vitamins or garlic supplements, or selective COX-2 inhibitor on precancerous gastric lesions. At baseline, all subjects (3,599 in 1994, and 2,813 in 2002) participated in an endoscopic screening survey and provided blood for DNA preparation and serology to detect H. pylori infection. At the end of the trial, another upper endoscopic examination and histologic diagnosis were conducted in all cohort subjects using the same procedures as the baseline. The detailed information of the study population, endoscope procedures, and criteria of gastric pathology had been described elsewhere (8, 32) . Briefly, for each subject, biopsy samples were taken from the standard locations of the stomach and given its corresponding histopathologic diagnosis by 3 senior pathologists of Peking University School of Oncology. Each biopsy was classified according to the presence or absence of superficial gastritis (SG), mild/severe CAG, IM, DYS, or GC. Each subject was assigned a global diagnosis based on the most severe diagnosis among any of the biopsies. Information on age, sex, and smoking status were obtained by questionnaires.
For the current study, a total of 248 GC cases were either identified from the baseline gastroscopic screenings or from hospitals in Linqu County during the follow-up period from 1994 to 2010. Because there were very few subjects with normal gastric mucosa in this population, 496 controls with SG/mild CAG were randomly selected from 2 cohorts and frequency matched to the GC cases by gender and age, according to baseline pathologic diagnosis. A total of 350 subjects with DYS at baseline from 2 cohorts were included and 496 subjects with IM were randomly selected from the same population as well. This study was approved by the Institutional Review Board of Peking University School of Oncology and all subjects gave written informed consent.
Blood sample collection and DNA preparation A 5-mL blood sample was collected from each subject. The blood sample was allowed to clot for 30 to 40 minutes at room temperature and then centrifuged at 965 g for 15 minutes. The resulting serum was separated into vials. The clot and serum were frozen immediately at À20 C and stored in a À70 freezer. High-molecular-weight genomic DNA was isolated by standard proteinase-K digestion and phenolchloroform extraction from the blood sample (33) .
Genetic variants screening and genotyping
A total of 80 subjects were randomly selected from the whole controls in our study for TLR2 and TLR5 screening by denaturing high-performance liquid chromatography (DHPLC). TLR genes fragments were amplified using primers designed by PRIMER 5.0 according to genomic reference sequences (GenBank accession number AC013303 and NM_003264 for TLR2, NC_000001 and NM_003268 for TLR5). PCR was accomplished with a 25-mL reaction mixture containing 100 ng of genomic DNA, 1.0 mmol/L of each primer, 0.1 mmol/L of dNTP and 1.0 U Taq DNA polymerase in 1X reaction buffer (Promega). DHPLC analysis was done on a Transgenomic WAVE System (Transgenomic Inc.). The detailed genotyping process was described previously (34) . Briefly, PCR products were denatured for 1 minute at 94 C and then gradually reannealed by decreasing the sample temperature from 94 C to 45 C over a period of 30 minutes to form homo-and/or hetero-duplexes. The PCR products were then applied to the DHPLC column at an optimal oven temperature and eluted with a linear acetonitrile gradient at a flow rate of 0.9 mL/min. The genotypes revealed by DHPLC analysis were further confirmed by DNA sequencing with ABI PRISM 3730. The primer sequences, PCR annealing temperatures and DHPLC oven temperatures are listed in Supplementary Table S1 .
For subsequent genotyping of all subjects, we developed PCR-restriction fragment length polymorphism approaches to determine genotypes of TLR5-889T>C, rs2072493, and rs5744174. The amplified PCR fragments were digested with appropriate restriction endonucleases and then resolved on 2% agarose gels. The restriction enzymes used for each polymorphism were as follows: BglII (New England Biolabs) for TLR5-889T>C, MfeI (New England Biolabs) for rs2072493 and HpyCH4IV (New England Biolabs) for rs5744174. DHPLC was done for analysis of TLR2-688G>T. For TLR2 c. À196 to À 174 ins>del, PCR products were directly visualized by electrophoresis on a 3.5% agarose gel.
Quality control procedures
To validate genotyping results, at least 5% samples were randomly selected for repeated genotyping. Furthermore, 1% samples were randomly selected for sequencing to validate the results. Samples with ambiguous results were repeated. For each 96-well plate, a negative control (no DNA template) was added to monitor PCR contamination.
H. pylori antibody assays
The serologic assay for H. pylori antibodies was described in detail previously (4) . Briefly, H. pylori strains from gastric biopsies of 5 patients in Linqu were cultured and used as local antigen preparation for serology. Serum levels of anti-H. pylori IgG and IgA were measured separately in duplicate with ELISA procedures. An individual was considered to be positive for H. pylori infection if the mean optical density for either the IgG or IgA >1.0, a cut-off value based on H. pylori negative persons and reference sera.
Statistical analysis
The Pearson's x 2 test was used to compare the basic characters and the genotypes between cases and controls.
Hardy-Weinberg equilibrium of the genotype distribution was tested by the goodness-of-fit x 2 test. ORs with corresponding 95% CIs were calculated by unconditional logistic regression, with adjustment for age, sex, H. pylori infection, and smoking status. For gene-gene or gene-H. pylori joint effect analysis, different gene-gene or gene-H. pylori combination categories were transformed into dummy variables and then except the category as reference, all the other categories entered the unconditional logistic regression model to calculate the adjusted ORs and 95% CIs for each category as compared with the reference. Multiplicative gene-gene or gene-H. pylori interactions were measured by including main effect variables and their product terms in the logistic regression model with likelihood ratio tests (35, 36) . A value of P < 0.05 was considered statistically significant. All the statistical analyses were done with SPSS (version 16.0). Linkage disequilibrium (LD) coefficients were calculated with Haploview 4.0 software.
Results
A total of 1,590 subjects were enrolled in our study, and the mean age was 57.8 years, with 1,215 (76.4%) males and 375 (23.6%) females. The baseline characteristics of the study population are summarized in Table 1 . Of the GC cases, 109 (44.0%) were intestinal, 104 (41.9%) diffuse, and 35 (14.1%) mixed type. The distributions of age and gender were similar in different groups. However, the percentage of H. pylori infection in IM, DYS, and GC cases was significantly different from those in controls.
To screen the profile of TLR2 and TLR5 polymorphisms, a total of 80 controls were randomly selected from all 1A) . Three variants (À688G>T, À264G>C, and c.2242ACA>del) were firstly identified in our study, which had not been reported in existing publications or relevant SNP databases (37) . Six polymorphisms: rs893629, rs893630, c. À196 to À 174 ins>del, rs3804099, rs3804100, and rs5743705 were reported previously. Among 9 variants, rs893629, rs893630, À264G>C, and c.2242ACA>del were rare ( 1%), whereas the minor allele frequencies (MAF) of À688G>T, c. À196 to À 174 ins>del, rs3804099, rs3804100 and rs5743705 were 1.9%, 36.9%, 40.7%, 38.1%, and 6.9%, respectively. As to TLR5, 9 genetic variants were identified (Fig. 1B) . Only À889T>C (MAF ¼ 13.1%) was firstly reported by our study (37) , which was in complete LD with another 4 polymorphisms (rs759303, rs1773766, rs2302597, and rs5744135). The MAFs for rs851181, rs45528236, rs2072493, and rs5744174 were 25.7%, 1.9%, 31.3%, and 20.7%, respectively. Given the frequencies and potential functions of the variants, we selected 2 polymorphisms in TLR2 (À688G>T and c. À196 to À 174 ins>del) and 3 in TLR5 (À889T>C, rs2072493, and rs5744174) to further investigate their associations with GC and its precursors. Other polymorphisms were not chosen either because of the low MAFs ( 1%) or silent polymorphisms.
We firstly evaluated the associations between genetic variants and GC risk. The frequencies of 5 polymorphisms in GC cases and controls are shown in Table 2 . The frequency distribution of each of the 3 genotypes fitted the Hardy-Weinberg equilibrium law in controls. There were no significant differences between case and control groups in the frequencies of TLR2-688G>T, TLR5-889T>C, and rs2072493 genotypes. However, the frequencies of the TLR2 c. À196 to À 174 ins>del genotypes in GC cases were significantly different from those in controls. Multivariate analyses adjusting for age, sex, H. pylori infection, and smoking status showed a significantly decreased risk of GC in subjects carrying TLR2 c. À196 to À 174 ins/delþdel/del genotype compared with the ins/ins genotype (OR, 0.66; 95% CI: 0.48-0.90). For TLR5, the frequencies of rs5744174 genotypes showed difference between GC cases and controls. Multivariate analyses indicated that an increased risk of GC was found in subjects with TCþCC genotype (OR, 1.43; 95% CI: 1.03-1.97), compared with those with the TT genotype.
Because both TLR2 c. À196 to À 174 ins>del and TLR5 rs5744174 showed significant associations with GC risk, we further evaluated their joint effects on GC risk ( Table  2 ). The subjects with 1 high-risk genotype of TLR2 c. À196 to À174 ins/ins or TLR5 rs5744174 (TCþCC) alone exhibited increased GC risk, and the OR was 1.43 (95% CI: 0.96-2.14) or 1.33 (95% CI: 0.87-2.04), respectively. Moreover, subjects carrying both high-risk genotypes had a significantly elevated risk of GC with an OR of 2.43 (95% CI: 1.49-3.96). However, no significant interaction was observed between TLR2 c. À196 to À 174 ins>del and TLR5 rs5744174, with the OR of 1.28 due to interaction (95% CI: 0.66-2.45). We also evaluated the joint effects between the TLR2 or TLR5 polymorphism and H. pylori infection on risk of GC (Table 3) . For TLR2 c. À196 to À174 ins>del, the OR of GC for subjects with the ins/ins genotype or H. pylori infection alone was 1.44 (95% CI: 0.88-2.33) or 2.16 (95% CI: 1.41-3.30), respectively; whereas the OR was elevated in subjects with ins/ins genotype and H. pylori infection (OR, 3.45; 95% CI: 2. 20-5.42) . No interaction between TLR2 c. À196 to À174 ins>del and H. pylori infection was found, with the OR of 1.11 due to interaction (95% CI: 0.59-2.11). As to TLR5 rs5744174, the OR of GC for subjects carrying the TCþCC genotype or H. pylori infection alone was 0.92 (95% CI: 0.56-1.52) or 1.69 (95% CI: 1.13-2.52), respectively. However, the risk was significantly elevated in subjects carrying the TCþCC genotype and H. pylori infection (OR, 3.35; 95% CI: 2.13-5.26). A significant interaction was found between the TCþCC genotype and H. pylori infection, with the OR of 2.15 due to interaction (95% CI: 1.12-4.16).
The risks of GC related to TLR2 c. À196 to À 174 ins>del and TLR5 rs5744174 were further examined with stratification by histologic types of GC. We found that TLR2 c. À196 to À 174 ins>del was only associated with risk of intestinal-type GC (OR, 0.59; 95% CI: 0.39-0.91), but not with diffuse-type GC (OR, 0.75; 95% CI: 0.49-1.16). Similar results were found for rs5744174 and subtypes of GC. The OR was 1.96 (95% CI: 1.28-3.01) for intestinal-type GC and 1.12 (95% CI: 0.71-1.76) for diffuse-type GC, respectively.
We further explored the associations between TLR2 c. À196 to À174 ins>del or TLR5 rs5744174 and risk of advanced gastric lesions. A total of 846 subjects with advanced gastric lesions including 350 DYS and 496 IM were enrolled in our study. The genotype frequencies of TLR2 c. À196 to À174 ins>del and TLR5 rs5744174 in IM and DYS are shown in Table 4 . No significant associations were found between genotypes of any loci and risk of DYS or IM. 
Discussion
In this study, we screened the genetic polymorphisms of TLR2 and TLR5 and investigated their associations with GC and its precursors in a Chinese population. We found significant associations between TLR2 c. À196 to À174 ins>del or TLR5 rs5744174 and risk of GC. Moreover, a significant interaction between TLR5 rs5744174 and H. pylori infection was observed. To our best knowledge, this is the first study to systematically screen the profile of TLR2 and TLR5 polymorphisms and investigate their associations with GC and its precursors.
TLR2 or TLR5 may play an important role in H. pylorirelated processes of inflammation and carcinogenesis. The TLR2 gene, mapped to chromosome 4q32, consists of 3 exons. Three major functional polymorphisms Pro631His, Arg677Trp, and Arg753Gln have been described in the Caucasian population (25, 38, 39) . However, these SNPs are absent in our screening population, consistent with the HapMap database and another report (28) . In our study, 3 novel genetic variants TLR2-688G>T, À264G>C and c.2242ACA>del were firstly reported, but the frequencies of À264G>C and c.2242ACA>del were less to 1%. We selected potentially functional polymorphisms À688G>T and c. À196 to À174 ins>del to evaluate the influence of genetic susceptibility on risk of GC, and found a significant association between TLR2 c. À196 to À174 ins>del and GC risk. A study in vitro has revealed that TLR2 c. À196 to À174 ins>del variant has a reduced transcriptional activity (40) . Another study has also shown that H. pylori-infected patients with TLR2 c. À196 to À 174 del genotype had lower risk of developing dyspeptic symptoms, suggesting that this polymorphism may modify H. pylori-related inflammatory response and outcome of H. pylori infection (41, 42) . However, 2 studies conducted in Japan showed no association or reverse association between TLR2 c. À196 to À174 ins>del and GC risk (24, 43) , suggesting that ethnic differences between Chinese and Japanese may influence the outcome of H. pylori-related carcinogenesis.
TLR5 is mapped to 1q41, containing 6 exons. A functional polymorphism TLR5 392STOP was found in Caucasians (44); but the SNP was absent in our population. A total of 9 genetic variants were identified in our study, including the firstly reported SNP À889T>C in the promoter region. Other 2 missense polymorphisms rs2072493 and rs5744174, encode the extracellular domain of TLR5 (45), which is characterized by the leucine-rich repeats that have been suggested to interact with ligands (45, 46) . In our study, we found rs5744174 TCþCC genotype was associated with elevated risk of GC. The rs5744174 T>C change causes a substitution of Leucine to Phenylalanine at amino acid 616, may likely affect the response of ligand recognition and the following signaling associated with inflammation, thus ultimately contributing to increased risk of GC (47) . Further study should be conducted to reveal the functional relevance.
Considering the potentially functional relevance between TLR2 or TLR5 and H. pylori infection, we were also interested to evaluate the possible interaction between TLR2 or TLR5 polymorphism and H. pylori infection. In our study, we observed significant joint effects of TLR2 c. À196 to À174 ins>del and H. pylori infection; whereas no significantly multiplicative interaction was seen between them. In contrast, we found a significant interaction between TLR5 rs5744174 and H. pylori infection. Although the precise mechanism of TLR5 polymorphism on the H. pylori-associated carcinogenesis is unclear, it may be reasonable that rs5744174 polymorphism could affect the ligand recognition, favoring H. pylori persistence in the stomach. Thus, in those subjects with high-risk genotype and H. pylori infection, increased secretion of proinflammatory cytokines due to persistent H. pylori infection amplify the chronic inflammation and ultimately the development of GC (47, 48) .
Intestinal type of GC is an end result of multistage transition of gastric mucosa over many years via the precancerous gastric lesions such as IM and DYS. We found that the effects of both TLR2 c. À196 to À 174 ins>del and TLR5 rs5744174 were more pronounced in intestinaltype GC than in diffuse-type GC. Therefore, we further investigated the relationship between TLR2 or TLR5 polymorphisms and advanced gastric lesions. However, no significant associations between genotypes of any loci and risk of IM or DYS were found, consistent with previous studies regarding inflammation-related gene polymorphisms and risk of precancerous gastric lesions (8, 49) . During the gastric carcinogenesis, there may be many factors to contribute to the outcome of gastric lesions such as strains of H. pylori, which could dilute the power to detect the effects of any one variant of TLR2 and TLR5. In addition, we used SG/mild CAG as controls in our study, which may diminish differences between controls and cases with IM or DYS, thus, the effects of TLR2 and TLR5 polymorphisms on the transition of gastric mucosa from the early to the advanced lesions might not be detected.
The strength of our study design was shown in certain aspects. First, the screening of TLR2 and TLR5 polymorphisms allowed us to obtain the profile of TLR2 and TLR5 genetic variants in the northern Chinese population. Second, the relatively large samples with a spectrum of gastric lesions allow us to evaluate the effects of TLR2 and TLR5 polymorphisms on gastric carcinogenesis. Furthermore, our population-based study has less selection bias and is more representative and reliable to draw a conclusion.
Our study also has some limitations. Because there were very few subjects with normal gastric mucosa in the population, we only selected subjects with SG/mild CAG as controls. Therefore, an independent case-control study including a more appropriate control group should be conducted. Moreover, the functional relevance of the newly identified polymorphisms and the exact mechanism of TLR polymorphisms on the H. pylori-associated carcinogenesis needs to be further clarified. In addition, our study subjects are restricted to Chinese population, limiting the generalizability of findings to other racial and ethnic groups.
In summary, this study is the first one to systematically investigate the genetic polymorphisms of TLR2 and TLR5 and their relationship with GC and its precursors. We found that TLR2 c. À196 to À174 ins>del and TLR5 rs5744174 were associated with GC risk. In addition, a significant interaction between rs5744174 and H. pylori infection was observed, suggesting that genetic and environmental factors contribute to the etiology of GC together. Further studies with ethnically diverse population in a larger sample size are warranted to confirm these findings.
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